Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.

Previous studies have suggested that human platelets can promote the activation of factor XI by two different mechanisms, one requiring factor XII and ADP-treated platelets and the other requiring collagen-treated platelets in the apparent absence of factor XII. To investigate these hypotheses. isolated platelets were tested for their capacity to promote the activation and cleavage of purified factors XII and Xl in various mixtures of purified factor XII. kallikrein. high molecular weight (HMW) kininogen. and factor XI. The activation of factor XII or factor XI was tested in clotting assays using plasmas deficient in factor XII. Xl. IX. or VII and the limited proteolytic cleavage of ‘25l-labeled factor XII or Xl was assessed using sodium dodecyl sulfate polyacrylamide gel electrophoresis in the presence of reducing agents. That ADPor collagentreated platelets can promote the proteolytic activation of factor XII in mixtures containing kallikrein and HMW kininogen was shown by: (1 ) the proteolytic cleavage of factor XII; (2) the development of factor XII, coagulant activity; and (3) the proteolytic cleavage of ‘25l-factor Xl. Platelets treated with collagen or thrombin were shown by both coagulant assays and by cleavage studies to participate

[1]  K. Fujikawa,et al.  The role of serine proteases in the blood coagulation cascade. , 1979, Advances in enzymology and related areas of molecular biology.

[2]  P. Walsh,et al.  Different Requirements for Intrinsic Factor-Xa Forming Activity and Platelet Factor 3 Activity and Their Relationship of Platelet Aggregation and Release , 1977, Thrombosis and Haemostasis.

[3]  J. Griffin,et al.  Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. J. Berman,et al.  Gel Filtration , 1971, Thrombosis and Haemostasis.

[5]  E. Davie,et al.  The Activation of Antihemophilic Factor (Factor VIII) by Activated Christmas Factor (Activated Factor IX) , 1964 .

[6]  P. Walsh,et al.  Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI. , 1979, The Journal of clinical investigation.

[7]  F. Dixon,et al.  A method of trace iodination of proteins for immunologic studies. , 1966, International archives of allergy and applied immunology.

[8]  J. Miletich,et al.  Relationships between platelets and coagulation factors in hemostasis. , 1978, Annual review of medicine.

[9]  G J Roth,et al.  Acetylation of prostaglandin synthase by aspirin. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Griffin,et al.  Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[11]  O. Ratnoff,et al.  The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents. , 1974, The Journal of clinical investigation.

[12]  O. Ratnoff.  The biology and pathology of the initial stages of blood coagulation. , 1966, Progress in hematology.

[13]  O. Ratnoff,et al.  Amidolytic properties of single-chain activated Hageman factor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Walsh,et al.  Hereditary Giant Platelet Syndrome , 1975 .

[15]  P. Walsh,et al.  Platelet coagulant activities and serum lipids in transient cerebral ischemia. , 1976, The New England journal of medicine.

[16]  J. Griffin,et al.  Human Prekallikrein (Plasminogen Proactivator): Purification, Characterization and Activation by Activated Factor XII , 1977, Thrombosis and Haemostasis.

[17]  J. Griffin.  Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Walsh.  Albumin Density Gradient Separation and Washing of Platelets and the Study of Platelet Coagulant Activities , 1972, British journal of haematology.

[19]  J. Griffin,et al.  Human factor XII (Hageman factor). , 1976, Methods in enzymology.

[20]  J. Vecchione,et al.  Procoagulant Activity of Platelets in Recalcified Plasma , 1975, British journal of haematology.

[21]  B. Osterud,et al.  Evidence against collagen activation of platelet-associated factor XI as a mechanism for initiating intrinsic clotting. , 2009, Scandinavian journal of haematology.

[22]  R. Colman,et al.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. , 1977, The Journal of clinical investigation.

[23]  R. Reisfeld,et al.  Protein iodination with solid state lactoperoxidase. , 1974, Biochemistry.

[24]  P. Henson,et al.  Activation of stimulus-specific serine esterases (proteases) in the initiation of platelet secretion. I. Demonstration with organophosphorus inhibitors , 1976, The Journal of experimental medicine.

[25]  O. Ratnoff,et al.  Detection by Fluorescence of Structural Changes Accompanying the Activation of Hageman Factor (Factor XII) , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  P. Walsh,et al.  The Role of Platelets in Intrinsic Factor‐Xa Formation , 1972, British journal of haematology.

[27]  P. Walsh.  Platelet Coagulant Activities in Thrombasthenia , 1972, British journal of haematology.

[28]  P. Walsh.  The Effects of Collagen and Kaolin on the Intrinsic Coagulant Activity of Platelets. EVIDENCE FOR AN ALTERNATIVE PATHWAY IN INTRINSIC COAGULATION NOT REQUIRING FACTOR XII , 1972, British journal of haematology.

[29]  D. Jackson,et al.  Purification and amino acid composition of monomeric and polymeric collagens. , 1967, The Biochemical journal.

[30]  A. Schmaier,et al.  Factor XI antigen and activity in human platelets. , 1982, Blood.

[31]  E. Cronkite,et al.  Morphology and enumeration of human blood platelets. , 1950, Journal of applied physiology.

[32]  J. Griffin,et al.  The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. , 1977, The Journal of clinical investigation.

[33]  G. Wilner,et al.  Activation of Hageman factor by collagen. , 1968, The Journal of clinical investigation.

[34]  P. Walsh,et al.  Metabolism and Function of Human Platelets Washed by Albumin Density Gradient Separation , 1977, British journal of haematology.

[35]  A. Kaplan,et al.  Association of factor XI and high molecular weight kininogen in human plasma. , 1977, The Journal of clinical investigation.

[36]  J. Griffin,et al.  Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. , 1977, The Journal of biological chemistry.

[37]  P. Walsh.  Platelet coagulant activities and hemostasis: a hypothesis. , 1974, Blood.

[38]  K. Weber,et al.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.

[39]  V. Marder,et al.  The Relationship of Platelet Coagulant Activities to Venous Thrombosis following Hip Surgery * , 1976, British journal of haematology.

[40]  J. Griffin,et al.  Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma , 1978, The Journal of experimental medicine.

[41]  J. Miletich,et al.  Properties of the factor Xa binding site on human platelets. , 1978, The Journal of biological chemistry.

[42]  Milstone Jh.  THROMBOKINASE AS PRIME ACTIVATOR OF PROTHROMBIN: HISTORICAL PERSPECTIVES AND PRESENT STATUS. , 1964 .

[43]  E. Marciniak.  Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex. , 1973, British journal of haematology.

[44]  J. Smith,et al.  Aspirin selectively inhibits prostaglandin production in human platelets. , 1971, Nature: New biology.

[45]  B. Ferris,et al.  Studies on human platelet protease activity. , 1968, The Journal of clinical investigation.

[46]  O. Ratnoff,et al.  Platelets and Surface‐Mediated Clotting Activity , 1979, British Journal of Haematology.

[47]  P. Walsh.  The Role of Platelets in the Contact Phase of Blood Coagulation , 1972, British journal of haematology.

[48]  P. Walsh.  The Effect of Dilution of Plasma on Coagulation: The Significance of the Dilution‐Activation Phenomenon for the Study of Platelet Coagulant Activities , 1972, British journal of haematology.